Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing ...

Drug rashes are a common side effect in people taking antiseizures, antibiotics, or anti-inflammatories. Find out specific ...

showing treatment with Dupixent resulted in a nearly 50% reduction in itch and urticaria activity scores compared to placebo More than 300,000 people in the U.S. suffer from CSU that is ...

Dupixent phase 3 study confirms significant improvements in itch ... treatment of patients with uncontrolled, biologic-naïve CSU receiving background therapy with antihistamines.

Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing treatment ... feeling, itching, skin rash, swollen ...

A Dupixent (dupilumab) confirmatory phase 3 study (LIBERTY-CUPID Study C) met the primary and key secondary endpoints for the investigational treatment ... standard-of-care antihistamines. With ...

showing treatment with Dupixent resulted in a nearly 50% reduction in itch and urticaria activity scores compared to placebo More than 300,000 people in the US suffer from chronic spontaneous ...

However, the disease remains uncontrolled despite antihistamine treatment in many patients ... general ill feeling, itching, skin rash, swollen lymph nodes, nausea or vomiting, or cramps in your ...

CSU is a chronic skin condition that causes sudden and debilitating hives and persistent itch, which can impact ... remains uncontrolled despite antihistamine treatment in many patients, some ...